Evidence map›Paper›PMID 25436823›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2014

HIV-positive status disclosure and use of essential PMTCT and maternal health services in rural Kenya.

Sydney A Spangler, Maricianah Onono, Elizabeth A Bukusi, Craig R Cohen, Janet M Turan

Abstract readComparative Study
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sydney A Spangler*Nell Hodgson Woodruff School of Nursing and Hubert Department of Global Health (HDGH), Emory University, Atlanta, GA; †Centre for Microbiology Research, Kenya Medical Research Institute (KEMRI), Centre for Microbiology Research, Nairobi, Kenya; ‡Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco (UCSF), San Francisco, CA; and §Department of Health Care Organization and Policy, University of Alabama at Birmingham (UAB), Birmingham, AL.
Maricianah Onono
Elizabeth A Bukusi
Craig R Cohen
Janet M Turan

Funding

Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4M
The Effects of HIV/AIDS Stigma on Use of Services by Pregnant Women in KenyaK01MH081777 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TURAN, JANET M. · 2007 to 2011
$842k
NIMH NIH HHS K01 MH081777NIMH NIH HHS K01MH081777NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

backgroundIn sub-Saharan Africa, women's disclosure of HIV-positive status to others may affect their use of services for prevention of mother-to-child transmission of HIV (PMTCT) of HIV and maternal and child health-including antenatal care, antiretroviral drugs (ARVs) for PMTCT, and skilled birth attendance.

methodsUsing data from the Migori and AIDS Stigma Study conducted in rural Nyanza Province, Kenya, we compared the use of PMTCT and maternal health services for all women by HIV status and disclosure category (n = 390). Among HIV-infected women (n = 145), associations between disclosure of HIV-positive status and the use of services were further examined with bivariate and multivariate logistic regression analyses.

resultsWomen living with HIV who had not disclosed to anyone had the lowest levels of maternity and PMTCT service utilization. For example, only 21% of these women gave birth in a health facility, compared with 35% of HIV-negative women and 49% of HIV-positive women who had disclosed (P < 0.001). Among HIV-positive women, the effect of disclosure to anyone on ARV drug use [odds ratio (OR) = 5.8; 95% confidence interval (CI): 1.9 to 17.8] and facility birth (OR = 2.9; 95% CI: 1.4 to 5.7) remained large and significant after adjusting for confounders. Disclosure to a male partner had a particularly strong effect on the use of ARVs for PMTCT (OR = 7.9; 95% CI: 3.7 to 17.1).

conclusionsHIV-positive status disclosure seems to be a complex yet critical factor for the use of PMTCT and maternal health services in this setting. The design of interventions to promote such disclosure must recognize the impact of HIV-related stigma on disclosure decisions and protect women's rights, autonomy, and safety.

Indexed as

DisclosureSocial StigmaAdolescentAdultAnti-HIV AgentsFemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalKenyaLongitudinal StudiesMaleMaternal Health ServicesMiddle AgedPregnancyYoung AdultAnti-HIV Agents

Identifiers

PMID25436823
PMCPMC4251910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.